Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Please feel free to read, share your thoughts, your stories and connect with others!
roadrunner
Posts: 516
Joined: Sun Jan 12, 2020 8:46 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby roadrunner » Wed Sep 11, 2024 4:23 pm

skb:

Can you advise where your nodules are—lung- and lobe-wise, I mean.

You may be able to combine surgery with SBRT or cryoablation, or even consider laser surgery (offered in Germany (at least)).

Also, FOLFIRI plus Avastin should at least be discussed.
7/19: RC: Staged IIIA, T2N1M0
approx 4.25 cm, low/mid rectum, mod. well diff.; lung micronodule
8/19-10/19 4 rds.FOLFOX neoadjuvant, 3 w/Oxiplatin (reduced 70-75%)
neoadjuvant chemorad 11/19
4 rounds FOLFOX July-August 2020
ncCR 10/20; biopsies neg
TAE 11/20
Chest CT 3/30/21 growth 2 nodules (3 and 5mm)
VATS 12/8/21 sub-pleural met 7mm.
SBRT nodule 1/22
6/20/22 TAE rectal polyp)
NED from 3/22 - 3/23
4 cycles FOLFIRI
LUL VATS lobectomy 7/7/23
5 cycles FOLFOX
APR 6/24. NED for now

skb
Posts: 115
Joined: Tue Mar 28, 2017 2:00 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby skb » Wed Sep 11, 2024 7:42 pm

The initial report just listed the largest nodule (7x7). I requested a re-reading because it had some obvious error (said I was on immunotherapy while I am actually on just chemotherapy)

My oncologist respectfully told me he felt that my request for details was an unproductive exercise and I should be getting some psychiatric assistance. He said I might be harming myself and my family by worrying too much. He added that I might benefit from hearing a different voice. Once he hung up, my normally stoic wife broke down in tears. She said she felt the doctor was disappointed in me.

I am careful not to share any results with my wife because I worry whether I am burdening her too much. I tell her only if she asks. I also message my oncologist only once in 3 months when the scan result is posted online.

Well, that is that. Im now trying to get an appt. with Dr. Prakash, another oncologist.

Nevertheless my current oncologist was nice enough to request a second reading. The following is the revised report I got yesterday.

1. Right upper lobe nodule (4/64) increasing in size now 7.5 x 7.5 mm.
(Inferior portion of RUL just above minor fissure)

* 1/20/23 not present
* 6/5/23 new 3 mm solid nodule RUL with adjacent arter
* 10/28/23 through 2/14/23 now with small extension to adjacent artery
* 5/15/24 still 3 mm original nodule but now more apparent extension and starting to look bilobed. If I measure the extension as part of the nodule you get 3 x 5 mm.
* 9/3/24 apparent growth and now multi lobulated single nodule measuring 7.5 x 7.5 mm


2. Surgical scar RLL is stable measuring 20 x 9 mm


3. Other nodules are also larger compared to 5/15/24

* LUL 3 mm nodule was 2 mm (4/55)
* LLL paired nodules (4/156) increased to 2 mm from 1 mm.
* RLL paired nodules (4127) increased from 3 mm each to a 4 mm and 5 mm nodule.


CHARLES DIETZ, MD
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm

User avatar
Green Tea
Posts: 545
Joined: Mon Oct 24, 2016 10:48 am

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby Green Tea » Wed Sep 11, 2024 8:55 pm

skb-
Right now I think your best bet is to press for a second opinion meeting with Dr. Prakash. He has a specialty in Gastrointestinal Medical Oncology, and furthermore he is doing cutting-edge research in colon cancer. and has received a 2024 colon cancer research award:

https://cancer.umn.edu/mezin-koats-colo ... arch-award

skb
Posts: 115
Joined: Tue Mar 28, 2017 2:00 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby skb » Wed Sep 11, 2024 9:17 pm

Thank you Green Tea.
I really respect and appreciate the suggestions from everyone on this forum
including you, Roadrunner, Utahgal
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm

skb
Posts: 115
Joined: Tue Mar 28, 2017 2:00 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby skb » Wed Sep 11, 2024 9:17 pm

Thank you Green Tea.
I really respect and appreciate the suggestions from everyone on this forum
including you, Roadrunner, Utahgal
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm

roadrunner
Posts: 516
Joined: Sun Jan 12, 2020 8:46 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby roadrunner » Wed Sep 11, 2024 9:51 pm

So it sounds as though you’ve got 6 likely pulmonary mets, distributed around the lungs. I also note that your thread title called your treatment “palliative therapy for oligometastatic colorectal cancer.” I’d be interested in who introduced those terms in the discussion and whether they were fully explained/discussed at that time. This may matter because the term “oligometastatic” is a marker for cases that might fall into a gray area as far as treatment options go. There certainly are a lot of oncologists and pulmonary surgeons who would look at this the way your current oncologist apparently does, but it may be that others would be more aggressive, potentially considering a combo of systemic and local treatment, with palliative or curative intent. And even if no one is interested in providing an aggressive curative approach, you may benefit from exploring ablation (RFA, SBRT, or cryoablation) under the heading of “palliative” therapy, or simply from advocating for it this way. For example, you may wish to educate yourself about the “abscopal effect” that can occasionally result from radio or other therapy on one/some metastases in contexts like yours. Also, while I don’t mean this negatively, you may wish to explore clinical trials—pulmonary mets, even if untreated, are usually slow growing, and yours are at an early stage. There may be trials out there right now (or coming) that could give you material benefit. All of this assumes, of course, that you are at least interested in pursuing aggressive options.

At the very least, all reasonable systemic options should be considered. I do not think Xeloda is usually considered SOC for multiple bilateral pulmonary mets, in any case. To me, it reflects a less aggressive systemic approach. Maybe that’s what you want, but that also should be discussed.

The overall point is that knowledge and clear communication/aligned goals with your team is at a premium now. It may well be worth getting second and third opinions, or more, even if you have to go far afield to get them. Assuming you have the desire and resources to do so, of course.

Finally, a bit of a rant. I don’t know how you interacted with your current oncologist, but given the context you’ve presented, his response sounds quite disappointing. Detail is your right in this situation—these are your lungs and it’s your life. Further, while the suggestion to seek psychiatric care may have been well-meant, it does not appear to have been productive in this context. I wonder if his training was sufficient to enable him to reliably identify psychological issues in this difficult context, or if it was just an expression of impatience and frustration? In any case, I think you are doing the right thing by seeking new counsel. I wish you strength and good fortune with this.
Last edited by roadrunner on Wed Sep 11, 2024 9:54 pm, edited 2 times in total.
7/19: RC: Staged IIIA, T2N1M0
approx 4.25 cm, low/mid rectum, mod. well diff.; lung micronodule
8/19-10/19 4 rds.FOLFOX neoadjuvant, 3 w/Oxiplatin (reduced 70-75%)
neoadjuvant chemorad 11/19
4 rounds FOLFOX July-August 2020
ncCR 10/20; biopsies neg
TAE 11/20
Chest CT 3/30/21 growth 2 nodules (3 and 5mm)
VATS 12/8/21 sub-pleural met 7mm.
SBRT nodule 1/22
6/20/22 TAE rectal polyp)
NED from 3/22 - 3/23
4 cycles FOLFIRI
LUL VATS lobectomy 7/7/23
5 cycles FOLFOX
APR 6/24. NED for now

roadrunner
Posts: 516
Joined: Sun Jan 12, 2020 8:46 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby roadrunner » Wed Sep 11, 2024 9:51 pm

So it sounds as though you’ve got 6 likely pulmonary mets, distributed around the lungs. I also note that your thread title called your treatment “palliative therapy for oligometastatic colorectal cancer.” I’d be interested in who introduced those terms in the discussion and whether they were fully explained/discussed at that time. This may matter because the term “oligometastatic” is a marker for cases that might fall into a gray area as far as treatment options go. There certainly are a lot of oncologists and pulmonary surgeons who would look at this the way your current oncologist apparently does, but it may be that others would be more aggressive, potentially considering a combo of systemic and local treatment, with palliative or curative intent. And even if no one is interested in providing an aggressive curative approach, you may benefit from exploring ablation (RFA, SBRT, or cryoablation) under the heading of “palliative” therapy, or simply from advocating for it this way. All of that assumes, of course, that you are interested in taking an aggressive approach if available. For example, you may wish to educate yourself about the “abscopal effect” that can occasionally result from radio or other therapy on one/some metastases in contexts like yours. Also, while I don’t mean this negatively, you may wish to explore clinical trials—pulmonary mets, even if untreated, are usually slow growing, and yours are at an early stage. There may be trial out there right now (or coming) that could give you material benefit. At the very least, all other reasonable systemic options should be considered. I do not think Xeloda is usually considered SOC for multiple bilateral pulmonary mets, in any case. To me, it reflects a less aggressive systemic approach. Maybe that’s what you want, but that also should be discussed.

The overall point is that knowledge and clear communication/aligned goals with your team is at a premium now. It may well be worth getting second and third opinions, or more, even if you have to go far afield to get them. Assuming you have the desire and resources to do so, of course.

Finally, a bit of a rant. I don’t know how you interacted with your current oncologist, but given the context you’ve presented, his response sounds quite disappointing. Detail is your right in this situation—these are your lungs and it’s your life. Further, while the suggestion to seek psychiatric care may have been well-meant, it does not appear to have been productive in this context. I wonder if his training was sufficient to enable him to reliably identify psychological issues in this difficult context, or if it was just an expression of impatience and frustration? In any case, I think you are doing the right thing by seeking new counsel. I wish you strength and good fortune with this.
7/19: RC: Staged IIIA, T2N1M0
approx 4.25 cm, low/mid rectum, mod. well diff.; lung micronodule
8/19-10/19 4 rds.FOLFOX neoadjuvant, 3 w/Oxiplatin (reduced 70-75%)
neoadjuvant chemorad 11/19
4 rounds FOLFOX July-August 2020
ncCR 10/20; biopsies neg
TAE 11/20
Chest CT 3/30/21 growth 2 nodules (3 and 5mm)
VATS 12/8/21 sub-pleural met 7mm.
SBRT nodule 1/22
6/20/22 TAE rectal polyp)
NED from 3/22 - 3/23
4 cycles FOLFIRI
LUL VATS lobectomy 7/7/23
5 cycles FOLFOX
APR 6/24. NED for now

skb
Posts: 115
Joined: Tue Mar 28, 2017 2:00 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby skb » Wed Sep 11, 2024 10:01 pm

Roadrunner,
Thank you for your very detailed reply.

I heard the term oligometastatic for the first time from you in Nov 2023.
"There’s a lot of material in this article that may be pertinent to your situation.

https://www.cancer.gov/news-events/canc ... eans%20few



"
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm

roadrunner
Posts: 516
Joined: Sun Jan 12, 2020 8:46 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby roadrunner » Wed Sep 11, 2024 10:08 pm

Ok, thanks for clarifying that. I think it may be important to see if future oncologists view your disease that way or as diffuse disease. From my perspective, it’s a discussion worth having. From what I’ve seen, there aren’t bright lines in circumstances like yours. I also think future conversations should include the shared understanding of whether the approach is “palliative,” “curative,” or perhaps “curative down the road if things go well.”
7/19: RC: Staged IIIA, T2N1M0
approx 4.25 cm, low/mid rectum, mod. well diff.; lung micronodule
8/19-10/19 4 rds.FOLFOX neoadjuvant, 3 w/Oxiplatin (reduced 70-75%)
neoadjuvant chemorad 11/19
4 rounds FOLFOX July-August 2020
ncCR 10/20; biopsies neg
TAE 11/20
Chest CT 3/30/21 growth 2 nodules (3 and 5mm)
VATS 12/8/21 sub-pleural met 7mm.
SBRT nodule 1/22
6/20/22 TAE rectal polyp)
NED from 3/22 - 3/23
4 cycles FOLFIRI
LUL VATS lobectomy 7/7/23
5 cycles FOLFOX
APR 6/24. NED for now

skb
Posts: 115
Joined: Tue Mar 28, 2017 2:00 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby skb » Fri Oct 04, 2024 11:40 pm

Adding avastin to Xeloda starting next week
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm

User avatar
beach sunrise
Posts: 1148
Joined: Thu Mar 05, 2020 7:14 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby beach sunrise » Fri Oct 18, 2024 11:54 pm

skb, just throwing this out there. ALA and vitamin C pair well with xeloda. It could give you more mileage. I have taken xeloda for 4 years and take ALA and vitamin C orally on days I don't get IVC. There are research papers on the benefit of ALA.
Beach
8/19 RC CEA 82.6 T3N0M0
5FU/rad 6 wk
IVC 75g 1 1/2 wks before surgery. Continue 2x a week
Surg 1/20 -margins T4bN1a IIIC G2 MSI- 1/20 LN+ LVI+ PNI-
pre cea 24 post 5.9
FOLFOX
7 rds 6-10 CEA 11.4 No more
CEA
7/20 11.1 8.8
8/20 7.8
9/20 8.8, 9, 8.6
10/20 8.1
11/20 8s
12/20 8s-9s
ADAPT++++ chrono
CEA
10/23/22 26.x
12/23/22 22.x
2023
1/5 17.1
1/20 15.9
3/30 14.9
6/12 13.3
8/1 2.1
Nodule RML SUV 1.3 5mm
Rolles 3 of 4 lung nodules cancer
KRAS
Chem-sens test failed Not enough ca cells to test

skb
Posts: 115
Joined: Tue Mar 28, 2017 2:00 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby skb » Wed Oct 23, 2024 3:04 pm

beach sunrise wrote:skb, just throwing this out there. ALA and vitamin C pair well with xeloda. It could give you more mileage. I have taken xeloda for 4 years and take ALA and vitamin C orally on days I don't get IVC. There are research papers on the benefit of ALA.
Beach

What is ALA?
3/17: Dx T3N0M0-mid rectal 4.5cm
4/18 to 5/17: chemoradiation- Xeloda and daily radiation (25 doses)
6/17: clean biopsy, clean scans
8/17: MRI - no evidence of tumor, no surgery, starts wait and watch
8/17 to 12/17: Folfox
8/19 VATS - 1cm lung nodule
7/21- Clean CT, CEA 15.6 !
8/21- PET , biopsy finds met in abdomen
10/21- Surgery , 12 rounds of FOLFIRI -ended 4/22
4/22 to 1/23- Clean scan, normal CEA
10/23- four sub-centimeter lung nodules, on Xeloda
9/24: CEA 5.6, largest nodule 7x7mm

J-man
Posts: 40
Joined: Tue Jan 29, 2013 4:14 am

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby J-man » Wed Oct 23, 2024 7:03 pm

skb wrote:What is ALA?

From a quick Google search
Alpha-Lipoic Acid (ALA)
https://www.webmd.com/diet/alpha-lipoic-acid-ala

utahgal7
Posts: 254
Joined: Fri Sep 11, 2020 12:04 pm

Re: Rising CEA while on palliative therapy for oligometastatic colorectal cancer

Postby utahgal7 » Thu Oct 24, 2024 1:30 am

skb,

Beachsunrise is correct about alpha lipoic acid synergy with 5-FU.

https://pmc.ncbi.nlm.nih.gov/articles/PMC6721634/ Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation (Paragraph 3.7 LA (lipoic acid) Synergizes with Standard Chemotherapeutics by Potentiating Cytotoxicity) Lipoic acid and alpha lipoic acid are the same. Based on this research article, the way I understand the mechanism behind alpha lipoic acid is that it synergizes with 5-FU regardless of P53 status, i.e. doesn't matter if your tumor is P53 mutant or P53 wild-type. If I am wrong about this, someone please correct me.

https://www.mdpi.com/2076-3921/13/8/897 The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment (Paragraph 4.1 Enhancing Chemotherapy and Radiotherapy Effects)

If you decide to try alpha lipoic acid, I hope it works for you.

Paige
02/20 Rectal Cancer dx - 4 cm mass; located 9 cm from AV
CEA 2.7; 0.9; 1.4; 0.9; 0.9; 1.2; 1.0; 0.8; 1.1; 1.0; 1.1; 1.7; 1.8; 1.8
1.9; 2.4; 2.3; 2.8; 2.2, 2.8, 3.2; 3.0; 1.6; 2.0; 1.2; 1.4; 1.2; 1.0
04/20 ST Radiation; 04/20 LAR surgery w/ileostomy; ypT3N1bM0; MSS, KRAS G12A
05/20 CAPEOX; 08/20 Ileostomy reversal
12/20 CT scan; lung nodules (watch and wait);
11/22 lung nodule biopsy positive for RC met;
1/23 VATS right lower lobe wedge resection
FOLFIRI 10 cycles
4/24 left brain craniotomy (RC met)


Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”



Who is online

Users browsing this forum: No registered users and 32 guests